| Of the roughly 6,000 genetic diseases we know of, only about 300 are treatable by drugs. But a new innovation is about the hit the mainstream… A “living drug” that could treat all 6,000. Full Story Here It’s no surprise that with the industry-changing potential of a breakthrough like this we’re about to see explosive breakouts from the companies best positioned to take advantage of it. And one specific stock is positioned perfectly in the center of it all. This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by OptionPub and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. There is a very high degree of risk involved in trading. Past results are not indicative of future returns. OptionPub and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for any trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. By downloading this book your information may be shared with our educational partners. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of OptionPub may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. |
an explosive trend is around the corner…
This email was sent to phanhoa1821960.trader@blogger.com by OptionPub
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment